Steadybase.

Bausch & Lomb Corp.

Website LinkedIn Latest 10-K
  • BLCO · NYSE
  • Ophthalmic Goods
  • Vaughan, A6
  • 13,000 employees
  • CIK 0001860742

Updated from SEC filings through

Top things to know

Executives

What leadership is saying

“Our third-quarter performance reflects the strength and breadth of the business, with growth across all three segments and continued expansion in profitability”

Thomas J. Appio, Chairman and interim CEO, Bausch + Lomb
Earnings press release (8-K Ex. 99.1), filed October 28, 2026

Bausch & Lomb Corp is a U.S. public company in ophthalmic goods (SIC 3851), headquartered in Vaughan, A6. It trades as BLCO on NYSE. Revenue was $5.1B in the fiscal year ending December 31, 2025, +6.5% from the year before. It reported about 13,000 employees.

Five-year financials

MetricFY2025FY2024FY2023FY2022FY2021
Revenue $5.1B
10-K, 2026-02-18
$4.8B
10-K, 2026-02-18
$4.1B
10-K, 2026-02-18
$3.8B
10-K, 2025-02-19
$3.8B
10-K, 2024-02-21
Operating income $113M
10-K, 2026-02-18
$162M
10-K, 2026-02-18
$130M
10-K, 2026-02-18
$207M
10-K, 2025-02-19
$329M
10-K, 2024-02-21
SG&A $2.2B
10-K, 2026-02-18
$2.1B
10-K, 2026-02-18
$1.7B
10-K, 2026-02-18
$1.5B
10-K, 2025-02-19
$1.4B
10-K, 2024-02-21
Net income -$360M
10-K, 2026-02-18
-$317M
10-K, 2026-02-18
-$260M
10-K, 2026-02-18
$6.0M
10-K, 2025-02-19
$182M
10-K, 2024-02-21

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Thomas J. Appio Chairman and interim CEO, Bausch + Lomb 8-K, October 28, 2026
Brent L. Saunders Chairman of the Board and CEO Form 4, August 7, 2026
Brenton L. Saunders Board member (per proxy)
bio: Chairman of the Board and Chief Executive Officer
DEF 14A, April 10, 2026
Sam Eldessouky Sam Eldessouky EVP and CFO Form 4, August 7, 2026
Andrew J. Stewart Andrew J. Stewart President, GPIC Form 4, August 7, 2026
Luc Bonnefoy Luc Bonnefoy President, Surgical Form 4, August 7, 2026
A. Robert D. Bailey EVP & Chief Legal Officer Form 4, August 7, 2026
Frederick Munsch
Senior Vice President- Controller and Chief Accounting Officer at Bausch + Lomb Corporation
SVP, Controller and CAO Form 4, August 12, 2026
Yehia Hashad Yehia Hashad EVP of R&D and CMO Form 4, August 7, 2026

What Bausch & Lomb Corp does

Bausch + Lomb Corporation (and its subsidiaries) (“Bausch + Lomb,” “we,” “us,” “our” or the “Company”) is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our mission is simple, yet powerful: helping you see better, to live better. Founded in 1853, Bausch + Lomb has a significant global research, development, manufacturing and commercial footprint of approximately 13,000 employees and a presence in approximately 100 countries.

Item 1. Business, 10-K for the year ending December 31, 2025

Shares and governance

Shares outstanding 357.5 million (as of October 21, 2026) 10-Q, October 28, 2026
Public float $557M (as of June 30, 2025) 10-K, February 18, 2026
Reportable segments 3 (period ending September 30, 2026) 10-Q, October 28, 2026
Latest proxy statement Meeting May 20, 2026 (filed April 10, 2026) DEF 14A, April 10, 2026
Auditor PricewaterhouseCoopers LLP (Florham Park, New Jersey) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
October 29, 2026 Frederick Munsch
SVP, Controller and CAO
Sale 112,015 $2.3M Form 4, November 2, 2026
August 10, 2026 Frederick Munsch
SVP, Controller and CAO
Sale 52,900 $888K Form 4, August 12, 2026
August 7, 2026 Eschenbach Andrew C. Von
Director
Sale 18,559 $307K Form 4, August 10, 2026
March 6, 2026 A. Robert D. Bailey
EVP & Chief Legal Officer
Buy 14,600 $250K Form 4, March 10, 2026
March 6, 2026 Sam Eldessouky
EVP and CFO
Buy 4,000 $69K Form 4, March 10, 2026
March 6, 2026 Brent L. Saunders
CEO and Chairman of the Board
Buy 14,700 $252K Form 4, March 10, 2026
March 3, 2026 Thomas W. Ross Sr.
Director
Buy 4,500 $80K Form 4, March 4, 2026
March 2, 2026 Eduardo Alfonso
Director
Buy 4,300 $77K Form 4, March 3, 2026

Recent 8-K events

  • 8-K filed 2026-10-28
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-10-28
    • Item 5.02 Departure or appointment of directors or officers; compensation
  • 8-K filed 2026-10-13
    • Item 5.02 Departure or appointment of directors or officers; compensation
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-08-06
    • Item 1.01 Entry into a material definitive agreement
    • Item 5.02 Departure or appointment of directors or officers; compensation
    • Item 8.01 Other events
  • 8-K filed 2026-07-29
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-05-20
    • Item 5.07 Submission of matters to a vote of security holders
  • 8-K filed 2026-04-29
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-02-18
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-01-02
    • Item 1.01 Entry into a material definitive agreement
    • Item 2.03 Creation of a direct financial obligation
    • Item 8.01 Other events
  • 8-K filed 2025-12-17
    • Item 5.02 Departure or appointment of directors or officers; compensation

Frequently asked questions about Bausch & Lomb Corp

What does Bausch & Lomb Corp do?
Bausch & Lomb Corp is classified by the SEC as Ophthalmic Goods (SIC 3851). It is based in Vaughan, A6.
What is Bausch & Lomb Corp's revenue?
$5.1B for the fiscal year ending December 31, 2025, from its 10-K filed February 18, 2026.
Is Bausch & Lomb Corp profitable?
Bausch & Lomb Corp reported net income of -$360M for the fiscal year ending December 31, 2025.
How many employees does Bausch & Lomb Corp have?
About 13,000 as of December 31, 2025, as stated in its annual report.
Who is the CFO of Bausch & Lomb Corp?
Sam Eldessouky, EVP and CFO, as named in a 4 filed August 7, 2026.
Where is Bausch & Lomb Corp headquartered?
Vaughan, A6.
What is Bausch & Lomb Corp's stock ticker?
BLCO on NYSE.
What industry is Bausch & Lomb Corp in?
Ophthalmic Goods, SIC code 3851.
What is Bausch & Lomb Corp's website?
bausch.com.
When does Bausch & Lomb Corp report earnings next?
January 27, 2027. Source: estimate_8k_pattern.
Is Bausch & Lomb Corp a public company?
Yes. Bausch & Lomb Corp files with the SEC under CIK 0001860742 and trades as BLCO.
Who audits Bausch & Lomb Corp?
PricewaterhouseCoopers LLP, Florham Park, New Jersey, as named in its latest annual report (10-K).
How many shares of Bausch & Lomb Corp are outstanding?
357.5 million shares as of October 21, 2026, from its 10-Q filed October 28, 2026.
What is Bausch & Lomb Corp's public float?
$557M as of June 30, 2025, as reported on the cover of its 10-K filed February 18, 2026.
How many business segments does Bausch & Lomb Corp report?
3 reportable segments for the period ending September 30, 2026, from its 10-Q filed October 28, 2026.
When is Bausch & Lomb Corp's annual shareholder meeting?
May 20, 2026, per its proxy statement (DEF 14A) filed April 10, 2026.
Have Bausch & Lomb Corp insiders traded stock recently?
Since February 19, 2026, officers and directors reported 3 open-market sales worth about $3.5M and 9 purchases worth about $1.2M on Forms 4 and 5. The most recent: Frederick Munsch (SVP, Controller and CAO) sold 112,015 shares on October 29, 2026.